Attributes | Values |
---|
rdf:type
| |
description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 2008 (ast)
- наукова стаття, опублікована в травні 2008 (uk)
- scientific article published on 02 May 2008 (en)
- مقالة علمية نشرت في 02 مايو 2008 (ar)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| |
rdfs:label
| - Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients (en)
- Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients (nl)
- Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients (ast)
|
skos:prefLabel
| - Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients (en)
- Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients (nl)
- Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients (ast)
|
name
| - Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients (en)
- Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients (nl)
- Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients (ast)
|
author
| |
author
| |
title
| |
title
| - Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1016/J.BREAST.2008.02.002
|
ResearchGate publication ID
| |
ResearchGate publication ID
| |
is about
of | |
is cites work
of | - Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366
- A novel model for Ki67 assessment in breast cancer
- Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
- Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
- A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Respons
- Correlation between Semi-Quantitative (18)F-FDG PET/CT Parameters and Ki-67 Expression in Small Cell Lung Cancer
- Breast cancer assessment tools and optimizing adjuvant therapy.
- Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer
- Correlation between Ki67 and breast cancer prognosis
- Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
- Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
- Ki67 in breast cancer: prognostic and predictive potential
- Thymidine kinase 1 upregulation is an early event in breast tumor formation
- Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
- Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro
- Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma
- Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas
- Paracrine control of tissue regeneration and cell proliferation by Caspase-3.
- Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry
- Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
- Publication of tumor marker research results: the necessity for complete and transparent reporting
- Overview of data-synthesis in systematic reviews of studies on outcome prediction models.
- Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
- An international Ki67 reproducibility study
- Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.
- Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53.
- Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer
- Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients
- Ki67 and proliferation in breast cancer
- Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer
- Expression of proliferation genes in formalin-fixed paraffin-embedded (FFPE) tissue from breast carcinomas. Feasibility and relevance for a routine histopathology laboratory
|